Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
298 studies found for:    Lymphoma AND (women OR woman OR female)
Show Display Options
RSS Create an RSS feed from your search for:
Lymphoma AND (women OR woman OR female)
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Gonadal Toxicity in Women With Hodgkin Lymphoma
Condition: Hodgkin Lymphoma
Intervention:
2 Recruiting Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
Conditions: Breast Cancer;   Lymphoma;   Hodgkin's Lymphoma
Interventions: Behavioral: surveys;   Other: Blood draw;   Device: Transvaginal ultrasounds
3 Completed Amifostine for Head and Neck Irradiation in Lymphoma
Conditions: Lymphoma;   Hodgkin's Disease;   Non-Hodgkin's Lymphoma
Interventions: Drug: Amifostine;   Radiation: Radiation Therapy
4 Completed Protection of Ovarian Function in Female Patients With Hodgkin Lymphoma
Condition: Hodgkins Lymphoma
Interventions: Drug: 8 cycles BEACOPPesc plus oral contraceptive;   Drug: 8 cycles BEACOPPesc plus Goserelin
5 Not yet recruiting Ivabradine in the Management of Cardiac Autonomic Dysfunction Associated With Thoracic Radiation Therapy.
Conditions: Lymphoma;   Autonomic Imbalance;   Cancer Survivorship
Interventions: Drug: Ivabradine;   Drug: Placebo Oral Tablet
6 Not yet recruiting Retrospective Analysis of Lymphomas and Cancers Synchronous Occurrence in Picardy From 2007 to 2012
Conditions: Lymphoma;   Cancer
Intervention: Other: Show an increase in incidence of cancers in patients with synchronous lymphoma
7 Completed Treatment of Follicular Lymphoma With High Dose Therapy and Stem Cell Support Followed by Rituximab and Alpha Interferon
Condition: Follicular Lymphoma
Interventions: Drug: Rituximab;   Drug: Alpha Interferon
8 Recruiting Lymphoma Bridge Transplant Study
Conditions: Hodgkin's Lymphoma;   Non-Hodgkin's Lymphoma
Interventions: Drug: Bendamustine;   Drug: Carmustine;   Drug: Etoposide;   Drug: Melphalan;   Drug: Cytarabine;   Drug: Alemtuzumab;   Biological: Autologous Stem Cell Transplantation;   Biological: Allogeneic Stem Cell Transplantation;   Drug: Rituximab
9 Completed Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma
Condition: Lymphoma
Interventions: Biological: pegfilgrastim;   Biological: rituximab;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: prednisone;   Drug: vincristine sulfate;   Other: pharmacological study;   Radiation: radiation therapy
10 Recruiting A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma (NHL) and in Combination With Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer
Condition: Non-Hodgkin's Lymphoma, Solid Cancers
Interventions: Drug: Fulvestrant;   Drug: GDC-0032;   Drug: Letrozole
11 Active, not recruiting Helical Irradiation of Total Skin (HITS) for Cutaneous Lymphoma
Condition: Cutaneous T-cell Lymphoma
Intervention: Radiation: HITS
12 Terminated Breast Magnetic Resonance Imaging (MRI) Screening After Mantle Radiation Therapy
Condition: Breast Cancer
Interventions: Procedure: Breast MRI;   Procedure: Mammogram
13 Suspended Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Dose-Adjusted-Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (DA-TEDDI-R) in Primary CNS Lymphoma
Condition: Primary Central Nervious System Lymphoma
Interventions: Drug: TEDDI;   Biological: Rituximab;   Drug: Cytarabine;   Drug: TEDD;   Drug: Ibrutinib
14 Not yet recruiting Cyclophosphamide and Alemtuzumab In Lymphoma
Conditions: Non Hodgkin Lymphoma;   High-grade B-cell Lymphoma;   CD52 Positive Non-Hodgkin Lymphoma;   DLBCL or High-grade B-cell Lymphoma NOS
Interventions: Drug: Cyclophosphamide;   Drug: Alemtuzumab
15 Enrolling by invitation Helical Irradiation of Total Skin (HITS) for T Cell Lymphoma
Condition: T-cell Lymphoma
Intervention:
16 Terminated
Has Results
CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma
Condition: T-cell Non-Hodgkin Lymphoma
Interventions: Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Etoposide;   Drug: Prednisone;   Drug: Filgrastim;   Drug: Plerixafor;   Procedure: Stem Cell Collection;   Drug: Palifermin;   Drug: Gemcitabine;   Drug: Busulfan;   Drug: Melphalan;   Procedure: Stem Cell Transplant
17 Recruiting T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas
Conditions: Lymphoma, Large-Cell, Anaplasitc;   Hodgkin Disease;   Lymphoma, Hodgkins;   Enteropathy-Associated T-Cell Lymphoma;   Lymphoma, Extranodal NK-T-Cell
Interventions: Biological: Anti-CD30-CAR T cells;   Drug: Cyclophosphamide;   Drug: Fludarabine
18 Completed Study of Adult T-Cell Leukemia/Lymphoma Among Carriers of HTLV-1
Condition: Human T-Lymphoma Virus Type I
Intervention:
19 Completed Study of Dynavax's 1018 ISS, Following Rituxan in Patients With B-Cell Follicular Lymphoma
Condition: Non-Hodgkin's Lymphoma
Interventions: Drug: Rituxan;   Drug: 1018 ISS
20 Recruiting A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)
Condition: Hepatosplenic T-Cell Lymphoma
Intervention: Biological: Collection of samples

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.